Impact of the Assumption in Charge of Medical Aid to the Procreation With Donation of Gametes on the Sexuality of the Couple

NCT ID: NCT03132818

Last Updated: 2020-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2017-07-20

Study Completion Date

2019-02-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sexual disorders associated with medical aid for procreation have already been demonstrated in several studies. However, few of them are interested in the problem of patients in charge of donating gametes, and if studied, it is often restricted to donating sperm to a small number of patients. For this reason, it would be interesting to study the impact of the intake and in charge and the treatments of the Medical Aid to the Procreation on this population of patients (including the patients treated in donation of sperm but also Those supported in oocyte donation)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sexuality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients undergoing AMP with oocyte donation

To evaluate the prevalence of sexual disorders in patients receiving AMP

Intervention Type OTHER

To evaluate the prevalence of sexual disorders in patients receiving AMP

Couples supported in AMP with sperm donation

To evaluate the prevalence of sexual disorders in patients receiving AMP

Intervention Type OTHER

To evaluate the prevalence of sexual disorders in patients receiving AMP

Couples supported in AMP intra torque

To evaluate the prevalence of sexual disorders in patients receiving AMP

Intervention Type OTHER

To evaluate the prevalence of sexual disorders in patients receiving AMP

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

To evaluate the prevalence of sexual disorders in patients receiving AMP

To evaluate the prevalence of sexual disorders in patients receiving AMP

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Couple, male and female, meeting the legal criteria for access to medically assisted procreation: a couple, a woman under the age of 43, who can testify to a life together. Then breakdown into 3 inclusion groups:

* Group 1: Patients undergoing AMP with oocyte donation
* Group 2: couples supported in AMP with sperm donation
* Group 3: torque supported in intra torque AMP.

Exclusion Criteria

* Patients who do not meet the legal criteria for access to the MPA.
* Patients in charge of Medical Assistance for Procreation "Viral Risk"
* Patients undergoing medical aid for procreation for pre-existing sexual dysfunction.
* Patients awaiting embryo reception.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire, Amiens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Amiens Picardie

Amiens, Picardie, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RNI2016-25 Dr Scheffler

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Contraception in Normal and Subnormal Men
NCT00167141 TERMINATED PHASE2